Circadian clock genes and psychiatric disorders

The Genetic Basis of Sleep and Sleep Disorders

Volumn , Issue , 2006, Pages 351-364

  Cuesta, Marc ^a   Cermakian, Nicolas ^a   Boivin, Diane B ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84923512332     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139649469.035     Document Type: Chapter

References (91)

1. Cermakian N, Boivin DB. The regulation of central and peripheral circadian clocks in humans. Obesity Rev. 2009;10(Suppl 2):25-36.
2. Boivin DB. Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders. J Psychiatry Neurosci. 2000; 25(5):446-58.
3. Lamont EW, Legault-Coutu D, Cermakian N, et al. The role of circadian clock genes in mental disorders. Dial Clin Neurosci. 2007;9(3): 333-42.
4. Persaud R. Nocturnal sweating and temperature in depression. Acta Psych Scand. 2000; 101(3):251.
5. Keller J, Flores B, Gomez RG, et al. Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry. 2006;60(3):275-81.
6. Pacchierotti C, Iapichino S, Bossini L, et al. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol. 2001;22(1): 18-32.
7. Pail G, Huf W, Pjrek E, et al. Bright-light therapy in the treatment of mood disorders. Neuropsychobiology. 2011;64(3): 152-62.
8. Wirz-Justice A. Chronobiology and mood disorders. Dial Clin Neuroscience. 2003;5(4): 315-25.
9. Soria V, Martinez-Amoros E, Escaramis G, et al. Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology. 2010;35(6):1279-89.
10. Utge SJ, Soronen P, Loukola A, et al. Systematic analysis of circadian genes in a populationbased sample reveals association of TIMELESS with depression and sleep disturbance. PloS ONE. 2010;5(2):e9259.
11. Kishi T, Kitajima T, Tsunoka T, et al. Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population. Neuromolec Med. 2009;11(2): 114-22.
12. Gouin JP, Connors J, Kiecolt- Glaser JK, et al. Altered expression of circadian rhythm genes among individuals with a history of depression. J Affect Disord. 2010;126(1-2):161-66.
13. Kronfeld-Schor N, Einat H. Circadian rhythms and depression: human psychopathology and animal models. Neuropharmacology. 2012;62(1):101-14.
14. Cuesta M, Mendoza J, Clesse D, et al. Serotonergic activation potentiates light resetting of the main circadian clock and alters clock gene expression in a diurnal rodent. Exp Neurol. 2008;210(2): 501-13.
15. Cuesta M, Clesse D, Pevet P, et al. New light on the serotonergic paradox in the rat circadian system. J Neurochem. 2009;110(1): 231-43.
16. Gannon RL, Millan MJ. Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on lightinduced phase advances in hamster circadian activity rhythms. Psychopharmacology. 2007;195(3):325-32.
17. Magnusson A, Boivin D. Seasonal affective disorder: an overview. Chronobiol Int. 2003;20(2): 189-207.
18. Schwartz PJ, Rosenthal NE, Kajimura N, et al. Ultradian oscillations in cranial thermoregulation and electroencephalographic slowwave activity during sleep are abnormal in humans with annual winter depression. Brain Res. 2000;866(1-2):152-67.
19. Partonen T, Treutlein J, Alpman A, et al. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med. 2007;39(3):229-38.
20. Johansson C, Willeit M, Smedh C, et al. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology. 2003;28(4):734-39.
21. Beck-Friis J, Ljunggren JG, Thoren M, et al. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test. Psychoneuroendocrinology. 1985;10(2):173-86.
22. Linkowski P, Kerkhofs M, Van Onderbergen A, et al. The 24- hour profiles of cortisol, prolactin, and growth hormone secretion in mania. Arch Gen Psychiatry. 1994;51(8):616-24.
23. Cervantes P, Gelber S, Kin FN, et al. Circadian secretion of cortisol in bipolar disorder. J Psychiatry Neurosci. 2001; 26(5):411-16.
24. Lamont EW, Coutu DL, Cermakian N, et al. Circadian rhythms and clock genes in psychotic disorders. Isr J Psychiatry Rel Sci. 2010;47(1): 27-35.
25. Etain B, Milhiet V, Bellivier F, et al. Genetics of circadian rhythms and mood spectrum disorders. Eur Neuropsychopharmacol. 2011; 21(Suppl 4):S676-82.
26. Serretti A, Cusin C, Benedetti F, et al. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am J Med Genet B Neuropsych Genet. 2005;137B(1):36-39.
27. Benedetti F, Serretti A, Colombo C, et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsych Genet. 2003;123B(1):23-26.
28. Serretti A, Benedetti F, Mandelli L, et al. Genetic dissection of psychopathological symptoms: insomnia in mood disorders and CLOCK gene polymorphism. Am J Med Genet B Neuropsych Genet. 2003;121B(1):35-38.
29. Benedetti F, Radaelli D, Bernasconi A, et al. Clock genes beyond the clock: CLOCK genotype biases neural correlates of moral valence decision in depressed patients. Genes Brain Behav. 2008;7(1):20-25.
30. Lee KY, Song JY, Kim SH, et al. Association between CLOCK 3111T/C and preferred circadian phase in Korean patients with bipolar disorder. Progr Neuropsychopharmacol Biol Psychiatry. 2010;34(7):1196-201.
31. Roybal K, Theobold D, Graham A, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA. 2007;104(15):6406-11.
32. Mukherjee S, Coque L, Cao JL, et al. Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior. Biol Psychiatry. 2010;68(6):503-11.
33. Hampp G, Ripperger JA, Houben T, et al. Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol. 2008;18(9):678-83.
34. Li J, Lu WQ, Beesley S, et al. Lithium impacts on the amplitude and period of the molecular circadian clockwork. PloS ONE. 2012;7(3):e33292.
35. LeSauter J, Silver R. Lithium lengthens the period of circadian rhythms in lesioned hamsters bearing SCN grafts. Biol Psychiatry. 1993;34(1-2):75-83.
36. Gould TD, Manji HK. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology. 2005;30(7):1223-37.
37. Iitaka C, Miyazaki K, Akaike T, et al. A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J Biol Chem. 2005;280(33):29397-402.
38. Kaladchibachi SA, Doble B, Anthopoulos N, et al. Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium. J Circad Rhythms. 2007;5:3.
39. McCarthy MJ, Nievergelt CM, Shekhtman T, et al. Functional genetic variation in the Rev- Erbalpha pathway and lithium response in the treatment of bipolar disorder. Genes Brain Behav. 2011;10(8):852-61.
40. Kozikowski AP, Gunosewoyo H, Guo S, et al. Identification of a glycogen synthase kinase-3beta inhibitor that attenuates hyperactivity in CLOCK mutant mice. Chem Med Chem. 2011; 6(9):1593-602.
41. Harvey AG. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry. 2008;165(7):820-29.
42. Stein MB, Chartier M, Walker JR. Sleep in nondepressed patients with panic disorder: I. Systematic assessment of subjective sleep quality and sleep disturbance. Sleep. 1993;16(8):724-26.
43. Sipila T, Kananen L, Greco D, et al. An association analysis of circadian genes in anxiety disorders. Biol Psychiatry. 2010; 67(12):1163-70.
44. Betcheva ET, Mushiroda T, Takahashi A, et al. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet. 2009; 54(2):98-107.
45. Keers R, Pedroso I, Breen G, et al. Reduced anxiety and depressionlike behaviours in the circadian period mutant mouse afterhours. PloS ONE. 2012;7(6):e38263.
46. Kraepelin E, Diefendorf, AR. Text Book of Psychiatry, 7th ed. London: Macmillan; 1907.
47. Cohrs S. Sleep disturbances in patients with schizophrenia: impact and effect of antipsychotics. CNS Drugs. 2008;22(11):939-62.
48. Manoach DS, Stickgold R. Does abnormal sleep impair memory consolidation in schizophrenia? Front Hum Neurosci. 2009; 3:21.
49. Martin J, Jeste DV, Caliguiri MP, et al. Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia patients. Schizophr Res. 2001;47(1):77-86.
50. Martin JL, Jeste DV, Ancoli- Israel S. Older schizophrenia patients have more disrupted sleep and circadian rhythms than agematched comparison subjects. J Psychiatr Res. 2005;39(3):251-59.
51. Wulff K, Joyce E, Middleton B, et al. The suitability of actigraphy, diary data, and urinarymelatonin profiles for quantitative assessment of sleep disturbances in schizophrenia: a case report. Chronobiol Int. 2006; 23(1-2):485-95.
52. Wulff K, Porcheret K, Cussans E, et al. Sleep and circadian rhythm disturbances: multiple genes and multiple phenotypes. Curr Opin Genet Dev. 2009;19(3):237-46.
53. Kishi T, Kitajima T, Ikeda M, et al. Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population. Eur Arch Psychiatry Clin Neurosci. 2009; 259(5):293-97.
54. Takao T, Tachikawa H, Kawanishi Y, et al. CLOCK gene T3111C polymorphism is associated with Japanese schizophrenics: a preliminary study. Eur Neuropsychopharmacol. 2007;17(4):273-76.
55. Tandon R. Cholinergic aspects of schizophrenia. Br J Psychiatry Suppl. 1999;37:7-11.
56. Mansour HA, Talkowski ME, Wood J, et al. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord. 2009;11(7):701-10.
57. Oliver PL, Sobczyk MV, Maywood ES, et al. Disrupted circadian rhythms in a mouse model of schizophrenia. Curr Biol. 2012;22(4):314-19.
58. Wu YH, Swaab DF. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. Sleep Med. 2007;8(6):623-36.
59. Cardinali DP, Furio AM, Brusco LI. Clinical aspects of melatonin intervention in Alzheimer's disease progression. Curr Neuropharmacol. 2010;8(3): 218-27.
60. Yesavage JA, Noda A, Hernandez B, et al. Circadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer disease. Am J Geriatr Psychiatry. 2011;19(7):635-43.
61. Cermakian N, Lamont EW, Boudreau P, et al. Circadian clock gene expression in brain regions of Alzheimer's disease patients and control subjects. J Biol Rhythms. 2011;26(2):160-70.
62. Sterniczuk R, Dyck RH, Laferla FM, et al. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes. Brain Res. 2010;1348:139-48.
63. Trampus M, Ferri N, Adami M, et al. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat. Eur J Pharmacol. 1993;235(1):83-87.
64. Djamshidian A, O'Sullivan SS, Papadopoulos A, et al. Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour. J Neurol Neurosurg Psychiatry. 2011;82(10):1107-11.
65. Sandyk R. The accelerated aging hypothesis of Parkinson's disease is not supported by the pattern of circadian melatonin secretion. Int J Neurosci. 1997;90(3-4):271-75.
66. Hua P, Liu W, Zhao Y, et al. Tef polymorphism is associated with sleep disturbances in patients with Parkinson's disease. Sleep Med. 2012;13(3):297-300.
67. Kripke DF, Nievergelt CM, Joo E, et al. Circadian polymorphisms associated with affective disorders. J Circad Rhythms. 2009;7:2.
68. Kudo T, Loh DH, Truong D, et al. Circadian dysfunction in a mouse model of Parkinson's disease. Exp Neurol. 2011;232(1):66-75.
69. Taylor N, Bramble D. Sleep disturbance and Huntington's disease. Br J Psychiatry. 1997; 171:393.
70. Goodman AO, Morton AJ, Barker RA. Identifying sleep disturbances in Huntington's disease using a simple disease-focused questionnaire. PLoS Curr. 2010;2: RRN1189.
71. Videnovic A, Leurgans S, Fan W, et al. Daytime somnolence and nocturnal sleep disturbances in Huntington disease. Parkinsonism Rel Disord. 2009;15(6):471-74.
72. Morton AJ, Wood NI, Hastings MH, et al. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J Neurosci. 2005;25(1):157-63.
73. Aziz NA, Pijl H, Frolich M, et al. Increased hypothalamic- pituitary-adrenal axis activity in Huntington's disease. J Clin Endocrinol Metab. 2009;94(4): 1223-28.
74. Aziz NA, Pijl H, Frolich M, et al. Delayed onset of the diurnal melatonin rise in patients with Huntington's disease. J Neurol. 2009;256(12):1961-65.
75. Pallier PN, Maywood ES, Zheng Z, et al. Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease. J Neurosci. 2007;27(29): 7869-78.
76. Cuesta M, Aungier J, Morton AJ. The methamphetamine-sensitive circadian oscillator is dysfunctional in a transgenic mouse model of Huntington's disease. Neurobiol Dis. 2012;45(1):145-55.
77. Dowling GA, Burr RL, Van Someren EJ, et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc. 2008;56(2):239-46.
78. Paus S, Schmitz-Hubsch T, Wullner U, et al. Bright light therapy in Parkinson's disease: a pilot study. Movement Disord. 2007;22(10):1495-98.
79. Sansone RA, Edwards HC, Forbis JS. Sleep quality in borderline personality disorder: a crosssectional study. Prim Care Companion J Clin Psychiatry. 2010;12(5).
80. Battaglia M, Ferini-Strambi L, Smirne S, et al. Ambulatory polysomnography of neverdepressed borderline subjects: a high-risk approach to rapid eye movement latency. Biol Psychiatry. 1993;33(5):326-34.
81. Battaglia M, Ferini Strambi L, Bertella S, et al. First-cycle REM density in never-depressed subjects with borderline personality disorder. Biol Psychiatry. 1999;45(8):1056-58.
82. Verkes RJ, Pijl H, Meinders AE, et al. Borderline personality, impulsiveness, and platelet monoamine measures in bulimia nervosa and recurrent suicidal behavior. Biol Psychiatry. 1996; 40(3):173-80.
83. Lieb K, Rexhausen JE, Kahl KG, et al. Increased diurnal salivary cortisol in women with borderline personality disorder. J Psychiatr Res. 2004;38(6):559-65.
84. King LA, Broyles SJ. Wishes, gender, personality, and wellbeing. J Person. 1997;65(1):49-76.
85. Hogben AL, Ellis J, Archer SN, et al. Conscientiousness is a predictor of diurnal preference. Chronobiol Int. 2007;24(6): 1249-54.
86. Gropman AL, Elsea S, Duncan WC, Jr., et al. New developments in Smith-Magenis syndrome (del 17p11.2). Curr Opin Neurol. 2007;20(2):125-34.
87. Boudreau EA, Johnson KP, Jackman AR, et al. Review of disrupted sleep patterns in Smith- Magenis syndrome and normal melatonin secretion in a patient with an atypical interstitial 17p11.2 deletion. Am J Med Genet A. 2009;149A(7): 1382-91.
88. Boone PM, Reiter RJ, Glaze DG, et al. Abnormal circadian rhythm of melatonin in Smith-Magenis syndrome patients with RAI1 point mutations. Am J Med Genet A. 2011;155A(8):2024-27.
89. Walz K, Spencer C, Kaasik K, et al. Behavioral characterization of mouse models for Smith- Magenis syndrome and dup(17) (p11.2p11.2). Hum Molec Genet. 2004;13(4):367-78.
90. Williams SR, Zies D, Mullegama SV, et al. Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity. Am J Hum Genet. 2012;90(6):941-49.
91. Novakova M, Nevsimalova S, Prihodova I, et al. Alteration of the circadian clock in children with Smith-Magenis syndrome. J Clin Endocrinol Metab. 2012; 97(2):E312-18.